Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia

NCT00105521 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

398

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease
Dyskinesia

Interventions

DRUG: Sarizotan
DRUG: Placebo

Sponsor

EMD Serono